Jan Kaiserle

The development of experimental treatments for muscular dystrophy is moving toward human trials in 2028 following encouraging results in preclinical mouse models. This milestone represents a significant leap in the application of Anthropic's Claude AI within the pharmaceutical sector, specifically

Addressing the chronic ischemia found in diabetic ulcers requires the upregulation of vascular endothelial growth factor, a process achievable through ultrasound-microbubble therapy. The skin functions as a highly sophisticated, multi-layered organ that maintains a constant state of flux, balancing

Standardizing the digital information gathered from daily life provides a unique opportunity to refine the accuracy of algorithms used in computational psychiatry. For years, the psychiatric community has struggled with a paradox: while patients carry devices that record every heartbeat and sleep

Specialized logistics firms like Cryoport Inc. held a 4% market share in 2025, highlighting the critical role of cold chain infrastructure in transporting temperature-sensitive live cell products. This reality emphasizes a profound shift within the pharmaceutical sector, where the focus is

Warp Sciences emerged from stealth on October 22 with $215 million in funding and a proposal to automate more of the chemistry behind drug research. The company describes a U.S.-based contract research organization combining AI, robotics, and medicinal chemistry. Its launch puts a concrete

Rare retinal diseases like MacTel often lead to the development of abnormal blood vessels and the permanent loss of clear central vision. This challenging medical reality has prompted Alcon, a global leader in eye care, to enter into a definitive agreement to acquire Neurotech Pharmaceuticals for

The healthcare industry is witnessing a pivotal shift as the Food and Drug Administration fundamentally reimagines the regulatory pathway for treatments targeting rare conditions that affect millions of Americans. While the pharmaceutical landscape has historically prioritized blockbuster drugs

The Telephone Consumer Protection Act creates a strict legal framework focused on patient consent and the right to privacy regarding mobile phone lines. In the high-stakes environment of 2026, medical professionals are rapidly adopting text messaging to bridge the communication gap between clinics

The $6.4 million settlement fund is designed to provide restitution for the exposure of private medical information while avoiding the costs and uncertainties of protracted litigation. This substantial payout marks a pivotal moment in the ongoing efforts to address the vulnerabilities inherent in

The $15 billion expansion of the Roche-Hansoh partnership signals a massive shift toward multi-program antibody-drug conjugate portfolios rather than traditional single-asset licensing deals. This momentous agreement, finalized in late 2026, represents a fundamental restructuring of how global